Skip to main content
. 2025;26(6):1931–1941. doi: 10.31557/APJCP.2025.26.6.1931

Table 1.

Abbreviations

Symbol Description Symbol Description
AEs Adverse Events HRs Hazard Ratios
CIs Confidence Intervals OC Ovarian Cancer
EOC Epithelial Ovarian Cancer PARPi Poly (ADP-iibose) Polymerase Inhibitors.
GRADE Grading of Recommendations, Assessment, Development, And Evaluation PFS Progression-Free Survival
HGSC High-Grade Serous Carcinoma RCTs Randomized Controlled Trials
HRD Homologous Recombination Deficit RRs Risk Ratios